Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
CCSD Code

CCSD code A7300 – Peripheral nerve permanent lesion


Code Definition

A7300 is the CCSD code for radiofrequency (including pulsed denervation), cryoprobe or phenol for permanent lesion of named peripheral nerve +/– image guidance. It covers a procedure that deliberately destroys or disrupts a named peripheral nerve to give lasting pain relief. A temporary local anesthetic block is coded elsewhere, as A7352 or A7302.

UK private medical insurers such as Bupa, AXA Health, Aviva and Vitality pay specialists against the CCSD schedule. A7300 sits in Chapter 3 under other nerve blocks, at Intermediate 1 complexity, and the 2026 Bupa CCSD reference lists it at £245.

Group
3 Spine, spinal cord and peripheral nerves
Category
Other Nerve Blocks
Subcategory
Other nerve blocks
Code also known as
radiofrequency denervation, RF nerve ablation, cryoneurolysis, pulsed RF, chemical neurolysis
Save time. Improve accuracy. Get paid faster.
Automate coding with Pabau

Let Pabau's smart automation suggest the right codes, reduce claim denials, and keep your practice compliant—effortlessly.

  • AI-powered code suggestions
  • Real-time compliance checks
  • Faster claims, fewer denials
Why practices choose Pabau
Save hours every week

Automate repetitive tasks and focus on what matters most—your patients.

Improve accuracy

Reduce coding errors and ensure compliance with the latest regulations.

Get paid faster

Clean claims, fewer denials, and faster reimbursements.

Grow with confidence

Powerful insights and reporting to help your practice thrive.

HIPAA compliant SOC 2 certified GDPR-compliant Trusted by 4,000+ clinics worldwide

Key takeaways

Key takeaways

CCSD code A7300 covers a permanent lesion of a named peripheral nerve by radiofrequency, pulsed radiofrequency, cryoprobe or phenol, with or without image guidance.

It is a neurolytic procedure, so a temporary local anesthetic block of the same nerve belongs under A7352 or A7302 instead.

UK private medical insurers such as Bupa, AXA Health, Aviva and Vitality pay against it. The 2026 Bupa CCSD reference lists A7300 at Intermediate 1 with a £245 fee.

Radiofrequency denervation of the knee (A7301), trigeminal branches (AA460) and spinal nerve roots (A5763 to A5766) each have their own code.

The procedure note must name the nerve, its side and the modality used, and the insurer’s pre-authorization number must match the code billed.

Pabau’s practice management software keeps the CCSD code, the procedure note and the insurer claim in one patient record.

CCSD code A7300: Definition and clinical scope

CCSD code A7300 is the UK private healthcare procedure code for permanently lesioning a named peripheral nerve. The lesion is made with radiofrequency energy (conventional thermal or pulsed), a cryoprobe, or an injection of phenol. The official descriptor reads Radiofrequency (including pulsed denervation), cryoprobe or phenol for permanent lesion of named peripheral nerve +/- image guidance.

The code is maintained in the CCSD schedule (Clinical Coding and Schedule Development). That group is run by the UK private medical insurers Bupa, AXA Health, Aviva and Vitality. Each insurer applies its own fees and benefit rules on top of the shared descriptor.

A7300 sits in Chapter 3 of the schedule (“Spine, spinal cord and peripheral nerves”), under other nerve blocks. The 2026 Bupa CCSD reference places it in the Intermediate 1 (INTER 1) category with a £245 fee. The rest of the schedule is covered in our CCSD code library.

Three features set A7300 apart from its neighbors. The lesion is meant to be permanent, the nerve must be named, and three different modalities share one descriptor. Each feature has a direct documentation consequence.

Which modalities does A7300 cover?

A7300 covers four techniques across three modalities: Conventional radiofrequency, pulsed radiofrequency, cryoprobe neurolysis and phenol neurolysis. Their mechanisms differ, and so does the expected duration of nerve disruption. Some insurers look at that duration when they assess a repeat claim.

ModalityMechanismTypical duration of effectKey documentation note
Conventional radiofrequency (thermal RF)Heat from RF current destroys nerve tissue at 60 to 80°C6 to 18 months, with nerve regeneration possibleRecord temperature, duration (seconds), impedance, and electrode size
Pulsed radiofrequency (PRF)Short RF bursts at lower temperatures that modulate the nerve without destroying itUsually shorter and more variable than thermal RF, and the effect may reverseRecord pulse parameters, temperature ceiling and duration, and name PRF explicitly because some insurers assess it differently
Cryoprobe neurolysisFreeze-thaw cycles disrupt nerve architecture via ice crystal formationSeveral months, through Wallerian degeneration, with regeneration possibleRecord probe size, number and duration of freeze-thaw cycles, and minimum temperature reached
Phenol neurolysisChemical protein denaturation causing lasting nerve disruptionLonger-lasting than RF for many patients, though regeneration is still possibleRecord phenol concentration (%), volume injected (mL), and delivery method

Pulsed radiofrequency does not heat nerve tissue enough to destroy it the way conventional thermal RF does. Some UK insurers treat pulsed RF differently for benefit purposes, so check the insurer’s current policy before the procedure. Name the modality explicitly in the procedure note.

What counts as a named peripheral nerve?

A named peripheral nerve is one the procedure note identifies by its anatomical name and side. A note that refers only to “the painful area,” “periarticular nerves,” or “nerve branches” does not satisfy the descriptor.

The following peripheral nerves are commonly lesioned in UK interventional pain practice:

  • Greater and lesser occipital nerves: Occipital neuralgia and cervicogenic headache.
  • Suprascapular nerve: Refractory shoulder pain.
  • Lateral femoral cutaneous nerve: Meralgia paresthetica.
  • Intercostal nerves: Post-thoracotomy or rib-related neuropathic pain, with the dermatome level recorded.
  • Ilioinguinal, iliohypogastric and genitofemoral nerves: Chronic groin pain after surgery.
  • Peripheral branches around the hip or ankle: Joint pain where a specific sensory branch has been confirmed by a diagnostic block.

Spinal medial branch denervation for facet joint pain needs extra care. The paraspinal section of Chapter 3 carries neurolytic root block codes that name radiofrequency denervation and rhizolysis by spinal region. Confirm with the insurer which code it expects before you bill A7300 for spinal work.

Facet joint radiofrequency has its own codes in that paraspinal section, chosen by joint count. A5730 covers facet or sacroiliac joint radiofrequency thermocoagulation under X-ray control, including rhizolysis, for 4 to 6 joints. A session covering 1 to 3 joints is billed as A5720 instead.

A7300 and neighboring CCSD codes

The right neighboring code depends on the nerve treated and on whether the lesion is permanent. The guide below asks those two questions in order. The table after it gives each code’s full descriptor from the 2026 Bupa CCSD reference.

Decision guide for CCSD nerve procedures. Temporary blocks: A7352 local anesthetic block, MINOR 4, £166; A5743 and A5745 diagnostic medial branch blocks, £286 cervical and £245 lumbar. Permanent lesions: A7301 knee genicular nerves, MAJOR 1, £475; AA460 trigeminal branch, MAJOR 5, £650; A5763 to A5766 spinal levels, MAJOR 1, £475; A6012 minor nerve cryosurgery, INTER 1, £245; A7300 any other named peripheral nerve, INTER 1, £245. Source: Pabau's 2026 Bupa CCSD reference guide.
A7300 is the fallback once the knee, trigeminal branches, spinal levels and minor-nerve cryosurgery are ruled out. Fees come from Pabau’s 2026 Bupa CCSD reference guide.
CCSD codeDescriptorCategory and Bupa feeUse it instead of A7300 when
A7301Radiofrequency denervation of knee (under image guidance)MAJOR 1, £475The target is the genicular nerves of the knee
AA460Destruction of branch of trigeminal nerve (neurolytic/RF/cryoprobe)MAJOR 5, £650The lesion is on a trigeminal branch, such as the infraorbital or mental nerve
A5763 to A5766Neurolytic root block (radiofrequency denervation, thermocoagulation, cryotherapy or phenol, including rhizolysis) +/- image guidanceMAJOR 1, £475 (A5763, A5765, A5766)The lesion is at a cervical, thoracic, lumbar or caudal spinal level
A6012Cryosurgery of minor peripheral nerve (e.g. Mortons Neuroma) +/- ultrasound guidanceINTER 1, £245A minor nerve such as a Morton’s neuroma is frozen
A7352Local anaesthetic blockade of named major nerve or plexus +/- image guidance (as sole procedure)MINOR 4, £166The block is temporary, for diagnosis or short-term relief
A5743, A5745Medial branch block injection(s) +/- image guidance (including bilateral)INTER 2, £286 (cervical) and INTER 1, £245 (lumbar)The medial branch is injected as a diagnostic test before denervation

A7301 and A7300 both describe radiofrequency nerve lesioning, yet the knee code pays almost twice as much. Billing A7300 for genicular nerve ablation underclaims, and billing A7301 for another joint overclaims. Both errors show up on audit.

Trigeminal branches are carved out the same way. Destruction of a trigeminal branch by neurolytic injection, radiofrequency or cryoprobe bills under CCSD code AA460, never A7300.

Figures come from Pabau’s 2026 Bupa CCSD reference guide. Check current fees in the Bupa code search portal before you bill. Our guide to A7352 covers the local anesthetic block in more detail.

Image guidance under A7300

Image guidance is optional under A7300, because the “+/-” in the descriptor means the code applies with or without it. The descriptor does not say whether guidance attracts a separate fee.

That answer comes from each insurer’s own rules. CCSD descriptors that include “+/- image guidance” generally treat guidance as part of the procedure, so a separate radiology line rarely belongs on the claim. Billing one without insurer approval creates an overpayment risk and a likely audit finding.

  • Document the guidance modality: Record whether fluoroscopy, ultrasound or CT was used, and keep the saved images or screening log.
  • Check insurer rules before the procedure: Some insurers require image guidance as a condition of authorization rather than as a billing addition.
  • Radiologist involvement: If a radiologist provides the guidance, confirm whether that work is billed under their own code and name.
  • Fluoroscopy screening logs: Keep the radiation dose record with the procedure note.

Pro Tip

Build a procedure-specific checklist for A7300 that captures the named nerve, side, modality, energy parameters and image guidance type in one structured form. Complete it in the procedure room before the patient leaves, because notes written later carry far greater audit risk.

Documentation requirements for A7300 claims

A complete procedure note is the most important evidence behind an A7300 claim. It has to contain each element in the table below for the claim to survive an insurer audit.

Storing structured procedure notes in the patient’s clinical records next to the CCSD code means the evidence is ready when an insurer asks for it. Digital forms that capture procedure-specific fields at the point of care cut the risk of notes written after the fact.

Comprehensive patient records
Pabau’s patient record keeps the A7300 procedure note, consent form and imaging log together, so the evidence an insurer requests is ready to send.
Documentation elementWhat to recordWhy it matters for A7300
Named nerveFull anatomical name and laterality (e.g. “left suprascapular nerve”)Required by the descriptor, and an unnamed nerve is a likely denial
Modality usedConventional RF, pulsed RF, cryoprobe or phenol, stated explicitlySome insurers apply different benefit rules by modality, and a vague note invites an audit query
Energy or chemical parametersTemperature, duration and impedance for RF, cycle count and minimum temperature for cryo, and concentration and volume for phenolConfirms the procedure was performed as described and supports an audit defense
Image guidance recordGuidance used (ultrasound, fluoroscopy or CT), plus saved images or the screening logExpected whenever guidance is used, and the only evidence that it happened
Clinical indicationDiagnosis, diagnostic nerve block results if performed, and failed conservative measuresEstablishes medical necessity and is usually required for pre-authorization
Patient consentSigned procedure-specific consent, including risk of incomplete denervation and sensory changeInsurer audits and complaint investigations often check that consent is procedure-specific

Pre-authorization with Bupa, AXA Health, Aviva and Vitality

UK private medical insurers expect A7300 to be authorized before the procedure takes place. The patient usually contacts their insurer for an authorization number, and the practice quotes that number on the claim. Retrospective authorization is rarely accepted.

Each insurer sets its own criteria, and pulsed radiofrequency draws the most scrutiny. Insurers typically look for the following evidence of medical necessity:

  • Failed conservative management, such as physical therapy, medication or structured exercise over a set period.
  • A positive diagnostic block of the target nerve before the permanent lesion.
  • A referral to, or treatment by, a recognized pain medicine specialist.
  • A documented diagnosis that matches the nerve treated, such as occipital neuralgia for an occipital nerve lesion.

Fees differ by insurer even though the code is shared. Vitality and Healix publish online fee finders with CCSD-coded procedure fees. Bupa’s code search shows its own fee and authorization status. AXA Health and Aviva publish fee and code information through their specialist portals.

If the authorized code and the billed code differ, the claim stalls. Ask for a revised authorization before the procedure if the plan changes, for example from a peripheral nerve to the knee. Our guide to Bupa CCSD codes explains how Bupa recognizes a code and what each submission needs.

Common denial reasons for CCSD code A7300

Most A7300 denials trace back to a short list of documentation and coding errors. The table below maps each one to its fix.

Denial reasonRoot causePrevention
Unnamed nerveProcedure note records “nerve branches” or “periarticular” without anatomical specificityAlways document the full anatomical name and laterality of the target nerve
Modality not specifiedNote records “denervation” without stating RF, PRF, cryoprobe, or phenolName the exact modality, and for RF state thermal or pulsed and record the energy parameters
Image guidance claimed without documentationA separate guidance code or guidance fee is claimed but no imaging log or saved images are in the recordAttach the imaging record to the procedure note, and claim guidance only with evidence made at the time
Wrong code for the procedureA local anesthetic block code is billed for a lesion, or A7300 is billed for the knee, trigeminal or spinal workCheck the nerve and the intent against A7301, AA460, A5763 to A5766 and A7352 before selecting A7300
No pre-authorization obtainedThe insurer required authorization before the procedure, and the claim went in without itCheck the insurer’s criteria before scheduling, and keep the authorization number with the booking
Frequency limit exceededThe insurer limits how often the same nerve can be lesioned within a benefit periodTrack the date of the last A7300 claim for each nerve, and check the insurer’s rules before a repeat

How Pabau keeps A7300 billing in one record

Many pain practices still write the procedure note in one system and raise the insurer invoice in another. The CCSD code, the named nerve and the authorization number then have to be copied across by hand.

Pabau keeps those steps inside one patient record instead. Its claims software for specialists attaches the CCSD code to the procedure, links the supporting documents and sends the claim to UK insurers through Healthcode.

Automate claims through Healthcode
Pabau sends A7300 claims to Bupa, AXA Health, Aviva and Vitality through Healthcode, using the code and authorization number already in the record.
  • Select the code: Pick A7300 from the CCSD code library inside the patient’s encounter.
  • Attach the image guidance record: Link the imaging log or saved images to the procedure before the claim goes out.
  • Confirm the modality: Check that the linked note names the nerve, the side and the modality. Insurers audit the note as well as the code.
  • Add the authorization number: Store the insurer’s reference against the booking so it travels with the claim.
  • Track repeat procedures: Use the treatment history to see when each nerve was last lesioned before booking a repeat.

The result is a claim that matches its authorization and its evidence the first time. That means fewer queries from the insurer and faster payment for the practice.

Keep A7300 notes and insurer claims together

Pabau links the CCSD code, the procedure note and the imaging record to one claim, then sends it to UK insurers through Healthcode. Fewer claims come back for missing evidence.

Pabau practice management software for UK pain practices

Conclusion

A7300 pays only when the claim proves three facts: Which named nerve was lesioned, by which modality, and that no closer CCSD code fits. Settle those in the procedure room and agree them with the insurer at authorization. The claim then has little left to query.

Pabau helps UK pain practices bill CCSD codes from the clinical record outward, with the note, the code and the claim in one workflow. To see how it handles interventional pain billing, book a demo.

Continue your research

Continue your research

Billing a local anesthetic block instead? CCSD code A7352 covers local anesthetic blockade of a named major nerve or plexus, and how it differs from A7350 and A7302.

Billing multiple CCSD codes in one encounter? Bupa procedure codes fee schedule explains how Bupa structures chapter fees and applies unbundling rules across multi-code submissions.

Need to look up related Bupa CCSD codes? Bupa CCSD procedure codes covers the full Bupa CCSD framework, including code recognition and submission requirements.

Lesioning a cranial nerve inside the skull? CCSD code A2600 covers other intracranial destruction of a cranial nerve, away from the peripheral targets A7300 bills.

Frequently asked questions

What is CCSD code A7300?

CCSD code A7300 is the UK private healthcare code for radiofrequency (including pulsed denervation), cryoprobe or phenol for permanent lesion of a named peripheral nerve. It applies with or without image guidance. Pain specialists use it to bill Bupa, AXA Health, Aviva and Vitality.

Is A7300 a nerve block?

No. A7300 is a permanent neurolytic lesion of a named peripheral nerve, even though the schedule files it under other nerve blocks. A temporary local anesthetic block of a named major nerve or plexus is billed as A7352, and a continuous catheter block as A7302.

Is pulsed radiofrequency billed under A7300?

Yes. The descriptor names pulsed denervation alongside conventional radiofrequency, so both use A7300. Some UK insurers apply different benefit rules to pulsed RF. Check the insurer’s policy at authorization, and record the pulse parameters and temperature ceiling in the note.

Does A7300 include image guidance, or is that billed separately?

A7300 covers the procedure with or without image guidance, as the “+/-” in the descriptor shows. Insurers generally treat guidance as part of the procedure. Confirm with the insurer before adding any separate guidance line to the claim.

Which CCSD code covers radiofrequency denervation of the knee?

Radiofrequency denervation of the knee under image guidance has its own code, A7301. The 2026 Bupa CCSD reference lists it at MAJOR 1 with a £475 fee, against £245 for A7300. Use A7301 for genicular nerve ablation.

Which peripheral nerves qualify under A7300?

Any anatomically named peripheral nerve qualifies, provided the procedure note records its name and side. Common targets include the occipital, suprascapular, lateral femoral cutaneous, intercostal, ilioinguinal and genitofemoral nerves. Trigeminal branches use AA460, and spinal nerve roots use A5763 to A5766.

What are the most common reasons an A7300 claim is denied?

The leading causes are an unnamed nerve, an unstated modality and image guidance claimed without records. Missing pre-authorization, a neighboring code that fits better, and repeat claims inside the insurer’s benefit period also cause denials.

Avatar photo
Maja Popovska
Content Writer

Maja is a Senior Content Writer at Pabau, where she covers everything from practice management and compliance to medical aesthetics and patient experience. Off the clock: binging true crime docuseries, baking and dreaming about travel.
×